Home 1 Tiny Biotech's Blockbuster Opportunity in Heart Disease
 

Keywords :   


1 Tiny Biotech's Blockbuster Opportunity in Heart Disease

2015-03-23 00:02:59| Biotech - Topix.net

The U.S. Food and Drug Administration approved the first cholesterol-busting statin drug more than 20 years ago, and statins' proven ability to cut cholesterol levels has turned them into the most widely used drugs in America. However, for millions of people statin therapy alone fails, and that's why Esperion Therapeutics Lipitor every year, heart disease remains the No.

Tags: heart opportunity disease tiny

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11 HEXAGON TR SET UP
28.1121dc hg
28.111EX D
28.11 Bucchus IMP24 FMH-RSM/M
28.11
28.11specialites TA carmina 46-36
28.11HUNTER×HUNTER
28.11
More »